Skip to content

Sugammadex

Bridion (sugammadex) is an oligosaccharide pharmaceutical. Sugammadex was first approved as Bridion on 2008-07-25. It has been approved in Europe to treat neuromuscular blockade. Bridion's patents are valid until 2026-01-27 (FDA).
Trade Name Bridion
Common Name Sugammadex
Indication neuromuscular blockade
Drug Class
Sugammadex
Get full access now